German Fear At Flight From State Funds

4 September 1997

German Health Minister Horst Seehofer has warned that official reportson the first-half 1997 health budget deficit are contributing to push more people out of the state health funds and into private-sector insurance.

He also says the funds' income is stagnating in Germany as a whole and falling in the eastern states. While public-sector fund contribution rates will remain stable in western Germany, the eastern states' decline in fund income means that a new contributions rise cannot be ruled out.

The figures show a 1% decline in overall fund spending in first-half 1997, the first since reunification, but this hides 2.1% and 2.4% rises in outpatient and hospital treatment respectively, and a rise of only 0.3% in drug spending. The deficit is now running at 4 billion Deutschemarks ($2.18 billion), with western Germany accounting for 2.8 billion marks of the deficit.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight